Your browser doesn't support javascript.
loading
Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis.
Saberi, Sara; Cardim, Nuno; Yamani, Mohamad; Schulz-Menger, Jeanette; Li, Wanying; Florea, Victoria; Sehnert, Amy J; Kwong, Raymond Y; Jerosch-Herold, Michael; Masri, Ahmad; Owens, Anjali; Lakdawala, Neal K; Kramer, Christopher M; Sherrid, Mark; Seidler, Tim; Wang, Andrew; Sedaghat-Hamedani, Farbod; Meder, Benjamin; Havakuk, Ofer; Jacoby, Daniel.
Afiliação
  • Saberi S; Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor (S.S.).
  • Cardim N; Department of Cardiology, Cardiovascular MR and CT unit (UNICA), Hospital da Luz, Lisbon, Portugal (N.C.).
  • Yamani M; Mayo Clinic, Jacksonville, FL (M.Y.).
  • Schulz-Menger J; Charité Medical University Berlin, ECRC and Department of Cardiology, HELIOS Klinik Berlin-Buch, Clinic for Cardiology and Nephrology, DZHK partnersite Berlin, Germany (J.S-M.).
  • Li W; MyoKardia, Brisbane, CA (W.L., V.F., A.J.S.).
  • Florea V; MyoKardia, Brisbane, CA (W.L., V.F., A.J.S.).
  • Sehnert AJ; MyoKardia, Brisbane, CA (W.L., V.F., A.J.S.).
  • Kwong RY; Cardiovascular Division, Department of Medicine (R.Y.K., M.J-H.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Jerosch-Herold M; Cardiovascular Division, Department of Medicine (R.Y.K., M.J-H.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Masri A; Center for Hypertrophic Cardiomyopathy, Knight Cardiovascular Institute, Oregon Health & Science University, Portland (A.M.).
  • Owens A; Center for Inherited Cardiac Disease, Division of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia (A.O.).
  • Lakdawala NK; Department of Cardiovascular Medicine (N.K.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Kramer CM; Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville (C.M.K.).
  • Sherrid M; Hypertrophic Cardiomyopathy Program, NYU Langone Health, New York (M.S.).
  • Seidler T; Department of Cardiology and Pulmonology, University Medical Center Göttingen, Germany (T.S.).
  • Wang A; Duke Cardiology, Duke Health Center at Southpoint, Durham, NC (A.W.).
  • Sedaghat-Hamedani F; Department of Internal Medicine III, Institute for Cardiomyopathies, University of Heidelberg, Germany (F.S.-H., B.M.).
  • Meder B; Department of Internal Medicine III, Institute for Cardiomyopathies, University of Heidelberg, Germany (F.S.-H., B.M.).
  • Havakuk O; Department of Cardiology, Tel Aviv Medical Center, affiliated to Sackler School of Medicine, Tel Aviv University, Israel (O.H.).
  • Jacoby D; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT (D.J.).
Circulation ; 143(6): 606-608, 2021 02 09.
Article em En | MEDLINE | ID: mdl-33190524

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uracila / Benzilaminas / Cardiomiopatia Hipertrófica / Imagem Cinética por Ressonância Magnética Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uracila / Benzilaminas / Cardiomiopatia Hipertrófica / Imagem Cinética por Ressonância Magnética Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article